ENDRA Life Sciences Inc. (NDRA) Financials

NDRA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 7.6 million 2.4 million
2023-06-30 9.2 million 2.3 million
2023-03-31 6.7 million 2.2 million
2022-12-31 9.3 million 2.1 million

NDRA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.6 million 252739
2023-06-30 -2.3 million 255855
2023-03-31 -2.5 million 237279
2022-12-31 -3.1 million 290769

NDRA Net Income

No data available :(

NDRA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 3.3 million - 405773
2023-06-30 4.8 million - 444167
2023-03-31 2.4 million - 481618
2022-12-31 4.9 million - 518147

NDRA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 7.7 million
2023-06-30 6.0 million
2023-03-31 3.2 million
2022-12-31 3

NDRA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.6 million 1.3 million 243332
2023-06-30 - 1.4 million 1.3 million 247773
2023-03-31 27000 1.4 million 1.4 million 181616
2022-12-31 38563 1.7 million 1.3 million 326769

NDRA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 70449
2023-06-30 - 72713
2023-03-31 - 71042
2022-12-31 - 67769

NDRA

Price: $0.33

52 week price:
0.23
2.79

Earnings Per Share: -2.56 USD

P/E Ratio: -0.46

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 4700

Ebitda: -2.3 million

Market Capitalization: 3.9 million

Links: